A representation of the EGFR protein, which plays a role in the progression of lung tumors driven by mutations in the KRAS protein. This material relates to a paper that appeared in the 20 June, issue of Science Translational Medicine, published by AAAS. The paper, by H.P. Moll at Medical University of Viennain Vienna, Austria; and colleagues was titled, "Afatinib restrains K-RAS-driven lung tumorigenesis."
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.